Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 4/2015

01-07-2015 | Erratum

Erratum to: How do surgeons approach breast cancer surgery in Turkey? A national survey

Authors: Mustafa Emiroğlu, Abdullah Inal, İsmail Sert, Enver İlhan, Kemal Peker, Mehmet Ali Gulcelik, Hilmi Güngör, Semra Salimoğlu, Didem Can, Hülya Ellidokuz, Cengiz Aydın

Published in: Breast Cancer | Issue 4/2015

Login to get access

Excerpt

The correct name of the co-author should be ‘‘Mehmet Ali Gulcelik’’, and not ‘‘Mehmet Ali Gürçelik’’ as given in the original publication of the article. …
Metadata
Title
Erratum to: How do surgeons approach breast cancer surgery in Turkey? A national survey
Authors
Mustafa Emiroğlu
Abdullah Inal
İsmail Sert
Enver İlhan
Kemal Peker
Mehmet Ali Gulcelik
Hilmi Güngör
Semra Salimoğlu
Didem Can
Hülya Ellidokuz
Cengiz Aydın
Publication date
01-07-2015
Publisher
Springer Japan
Published in
Breast Cancer / Issue 4/2015
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-013-0507-x

Other articles of this Issue 4/2015

Breast Cancer 4/2015 Go to the issue

Case Report

HER-2 positive primary solid neuroendocrine carcinoma of the breast: a case report and review of the literature

Case Report

Two cases of primary small cell carcinoma of the breast showing non-mass-like pattern on diagnostic imaging and histopathology

Original Article

Phase II clinical trial of metronomic chemotherapy with combined irinotecan and tegafur–gimeracil–oteracil potassium in metastatic and recurrent breast cancer

Original Article

MRI and ultrasound evaluation of invasive lobular carcinoma of the breast after primary systemic therapy

Original Article

C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosis

Original Article

Thioglucose-bound gold nanoparticles increase the radiosensitivity of a triple-negative breast cancer cell line (MDA-MB-231)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits